Migraine as a Cerebral Ionopathy with Impaired Central Sensory Processing

Molecular Neurology

Volumn , Issue , 2007, Pages 439-461

  Ferrari, Michel D ^a   van den Maagdenberg, Arn M J M ^a   Frants, Rune R ^a   Goadsby, Peter J ^b,c  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84882473886     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-012369509-3.50030-5     Document Type: Chapter

References (244)

1. S. Afridi, N.J. Giffin, H. Kaube, K.J. Friston, N.S. Ward, R.S.J. Frackowiak and P.J. Goadsby (2005) A PET study in spontaneous migraine. Archives of Neurology 62 1270-1275.
2. S. Afridi, H. Kaube and P.J. Goadsby (2004) Glyceryl trinitrate triggers premonitory symptoms in migraineurs. Pain 110 675-680.
3. S. Afridi, M.S. Matharu, L. Lee, H. Kaube, K.J. Friston, R.S.J. Frackowiak and P.J. Goadsby (2005) A PET study exploring the laterality of brainstem activation in migraine using glyceryl trinitrate. Brain 128 932-939.
4. A.H. Ahn and A.I. Basbaum (2006) Tissue injury regulates serotonin 1D receptor expression: Implications for the control of migraine and inflammatory pain. J Neurosci 26 8332-8338.
5. S. Akerman and P.J. Goadsby (2005) Topiramate inhibits cortical spreading depression in rat and cat: impact in migraine aura. NeuroReport 16 1383-1387.
6. A. Ambrosini, M. D'Onofrio, G.S. Grieco, A. Di Mambro, D. Fortini and F. Nicoletti (2005) A new mutation on the ATPA2 gene in one Italian family with basilar-type migraine linked to the FHM2 locus. Neurology 64 A132.
7. W.K. Amery and J. Waelkens (1983) Prevention of the last chance: An alternative pharmacological treatment of migraine. Headache 23 37-38.
8. P. Andlin-Sobocki, B. Jonsson, H.U. Wittchen and J. Olesen (2005) Cost of disorders of the brain in Europe. Eur J Neurol 12 1-27.
9. V. Anttila, M. Kallela, G. Oswell, M.A. Kaunisto, D.R. Nyholt and E. Hamalainen (2006) Trait components provide tools to dissect the genetic susceptibility of migraine. Am J Hum Genet 79 85-99.
10. K. Asakura, T. Kanemasa, K. Minagawa, K. Kagawa, T. Yagami, M. Nakajima and M. Ninomiya (2000) α-Eudesmol, a P/Q-type Ca 2+ channel blocker, inhibits neurogenic vasodilation and extravasation following electrical stimulation of trigeminal ganglion. Brain Research 873 94-101.
11. C. Ayata, H. Jin, C. Kudo, T. Dalkara and M.A. Moskowitz (2006) Suppression of cortical spreading depression in migraine prophylaxis. Ann Neurol 59 652-661.
12. C. Ayata, M. Shimizu-Sasamata, E.H. Lo, J.L. Noebels and M.A. Moskowitz (2000) Impaired neurotransmitter release and elevated threshold for cortical spreading depression in mice with mutations in the alpha 1A subunit of P/Q type calcium channels. Neuroscience 95 639-645.
13. A. Bahra, A. May and P.J. Goadsby (2002) Cluster headache: A prospective clinical study in 230 patients with diagnostic implications. Neurology 58 354-361.
14. T. Bartsch and P.J. Goadsby (2002) Stimulation of the greater occipital nerve induces increased central excitability of dural afferent input. Brain 125 1496-1509.
15. T. Bartsch and P.J. Goadsby (2003) Increased responses in trigeminocervical nociceptive neurones to cervical input after stimulation of the dura mater. Brain 126 1801-1813.
16. T. Bartsch and P.J. Goadsby (2005) Anatomy and physiology of pain referral in primary and cervicogenic headache disorders. Headache Currents 2 42-48.
17. T. Bartsch, M.J. Levy, Y.E. Knight and P.J. Goadsby (2004) Differential modulation of nociceptive dural input to [hypocretin] Orexin A and B receptor activation in the posterior hypothalamic area. Pain 109 367-378.
18. M.T. Bassi, N. Bresolin, A. Tonelli, K. Nazos, F. Crippa and C. Baschirotto (2004) A novel mutation in the ATP1A2 gene causes alternating hemiplegia of childhood. J Med Genet 41 621-628.
19. A. Bergerot and P.J. Goadsby (2005) Distribution of the dopamine D1 and D2 receptors in the rat trigeminocervical complex. Cephalalgia 25 872.
20. A. Bergerot, R.J. Storer and P.J. Goadsby (2005) Dopamine inhibits trigeminovascular transmission in the rat. Cephalalgia 25 862.
21. C.T. Beuckmann and M. Yanagisawa (2002) Orexins: From neuropeptides to energy homeostasis and sleep/wake regulation. Journal of Molecular Medicine 80 329-342.
22. A. Bjornsson, G. Gudmundsson, E. Gudfinnsson, M. Hrafnsdottir, J. Benedikz and S. Skuladottir (2003) Localization of a gene for migraine without aura to chromosome 4q21. Am J Hum Genet 73 986-993.
23. O. Blin, J. Azulay, G. Masson, G. Aubrespey and G. Serratrice (1991) Apomorphine-induced yawning in migraine patients: Enhanced responsiveness. Clin Neuropharmacol 14 91-95.
24. H. Bolay, U. Reuter, A.K. Dunn, Z. Huang, D.A. Boas and M.A. Moskowitz (2002) Intrinsic brain activity triggers trigeminal meningeal afferents in a migraine model. Nature Medicine 8 136-142.
25. M.G. Bousser and K.M. Welch (2005) Relation between migraine and stroke. Lancet Neurol 4 533-542.
26. N. Breslau and G.C. Davis (1993) Migraine, physical health and psychiatric disorder: A prospective epidemiological study in young adults. Journal of Psychiatric Research 27 211-221.
27. N. Breslau, R.B. Lipton, W.F. Stewart, L.R. Schultz and K.M. Welch (2003) Comorbidity of migraine and depression: Investigating potential etiology and prognosis. Neurology 60 1308-1312.
28. R. Burstein, D. Yarnitsky, I. Goor-Aryeh, B.J. Ransil and Z.H. Bajwa (2000) An association between migraine and cutaneous allodynia. Annals of Neurology 47 614-624.
29. Z.M. Cader, S. Noble-Topham, D.A. Dyment, S.S. Cherny, J.D. Brown, G.P. Rice and G.C. Ebers (2003) Significant linkage to migraine with aura on chromosome 11q24. Hum Mol Genet 12 2511-2517.
30. Y.Q. Cao, E.S. Piedras-Renteria, G.B. Smith, G. Chen, N.C. Harata and R.W. Tsien (2004) Presynaptic Ca 2+ channels compete for channel type-preferring slots in altered neurotransmission arising from Ca 2+ channelopathy. Neuron 43 387-400.
31. A. Carlsson, L. Forsgren, P.O. Nylander, U. Hellman, K. Forsman-Semb and G. Holmgren (2002) Identification of a susceptibility locus for migraine with and without aura on 6p12.2-p21.1. Neurology 59 1804-1807.
32. W.A. Catterall (1998) Structure and function of neuronal Ca2+ channels and their role in neurotransmitter release. Cell Calcium 24 307-323.
33. A.S. Cohen and P.J. Goadsby (2004) Functional neuroimaging of primary headache disorders. Current Neurology and Neuroscience Reports 4 105-110.
34. N.J. Colson, R.A. Lea, S. Quinlan, J. MacMillan and L.R. Griffiths (2005) Investigation of hormone receptor genes in migraine. Neurogenetics 6 17-23.
35. M. De Fusco, R. Marconi, L. Silvestri, L. Atorino, L. Rampoldi and L. Morgante (2003) Haploinsufficiency of ATP1A2 encoding the Na +/K + pump α2 subunit associated with familial hemiplegic migraine type 2. Nature Genetics 33 192-196.
36. E. del Bene, M. Poggonioni and F. de Tommasi (1994) Video assessment of yawning induced by sublingual apomorphine in migraine. Headache 34 536-538.
37. M. Dichgans, T. Freilinger, G. Eckstein, E. Babini, B. Lorenz-Depiereux and S. Biskup (2005) Mutation in the neuronal voltage-gated sodium channel SCN1A causes familial hemiplegic migraine. The Lancet 366 371-377.
38. V. Dimitriadou, M.G. Buzzi, M.A. Moskowitz and T.C. Theoharides (1991) Trigeminal sensory fiber stimulation induces morphological changes reflecting secretion in rat dura mater mast cells. Neuroscience 44 97-112.
39. V. Dimitriadou, M.G. Buzzi, T.C. TheoharidTes and M.A. Moskowitz (1992) Ultrastructural evidence for neurogenically mediated changes in blood vessels of the rat dura mater and tongue following antidromic trigeminal stimulation. Neuroscience 48 187-203.
40. V. Domenga, P. Fardoux, P. Lacombe, M. Monet, J. Maciazek and L.T. Krebs (2004) Notch3 is required for arterial identity and maturation of vascular smooth muscle cells. Genes Dev 18 2730-2735.
41. H. Doods, G. Hallermayer, D. Wu, M. Entzeroth, K. Rudolf, W. Engel and W. Eberlein (2000) Pharmacological profile of BIBN4096BS, the first selective small molecule CGRP antagonist. British Journal of Pharmacology 129 420-423.
42. L.S. Dove, L.C. Abbott and W.H. Griffit (1998) Whole-cell and singlechannel analysis of P-type calcium currents in cerebellar purkinje cells of leaner mutant mice. Journal of Neuroscience 18 7687-7699.
43. A. Ducros, C. Denier, A. Joutel, M. Cecillon, C. Lescoat and K. Vahedi (2001) The clinical spectrum of familial hemiplegic migraine associated with mutations in a neuronal calcium channel. New England Journal of Medicine 345 17-24.
44. P.L. Durham and A.F. Russo (1999) Regulation of calcitonin generelated peptide secretion by a serotonergic antimigraine drug. Journal of Neuroscience 19 3423-3429.
45. P.L. Durham, R.V. Sharma and A.F. Russo (1997) Repression of the calcitonin gene-related peptide promoter by 5-HT1 receptor activation. Journal of Neuroscience 17 9545-9553.
46. I.O. Ebrahim, R.S. Howard, M.D. Kopelman, M.K. Sharief and A.J. Williams (2002) The hypocretin/orexin system. Journal of the Royal Society of Medicine 95 227-230.
47. L. Edvinsson, R. Ekman, I. Jansen, J. McCulloch and R. Uddman (1987) Calcitonin gene-related peptide and cerebral blood vessels: Distribution and vasomotor effects. Journal of Cerebral Blood Flow and Metabolism 7 720-728.
48. L. Edvinsson, S. Rosendahl-Helgesen and R. Uddman (1983) Substance P: Localization, concentration and release in cerebral arteries, choroid plexus and dura mater. Cell and Tissue Research 234 1-7.
49. M. Fanciullacci, M. Alessandri, M. Figini, P. Geppetti and S. Michelacci (1995) Increase in plasma calcitonin gene-related peptide from extracerebral circulation during nitroglycerin-induced cluster headache attack. Pain 60 119-123.
50. M.D. Ferrari (1998) Migraine. The Lancet 351 1043-1051.
51. M.D. Ferrari and P.J. Goadsby (2006) Migraine as a cerebral ionopathy with abnormal central sensory processing. S. Gilman, T. Pedley (Eds) Neurobiology of disease New York: Elsevier in press
52. S.M. Fleetwood-Walker, P.J. Hope and R. Mitchell (1988) Antinociceptive actions of descending dopaminergic tracts on cat and rat dorsal horn somatosensory neurones. J Physiol 399 335-348.
53. C.F. Fletcher, A. Tottene, V.A. Lennon, S.M. Wilson, S.J. Dubel and R. Paylor (2001) Dystonia and cerebellar atrophy in CACNA1A null mice lacking P/Q calcium channel activity. FASEB J 15 1288-1290.
54. L. Friberg, J. Olesen, H.K. Iversen and B. Sperling (1991) Migraine pain associated with middle cerebral artery dilatation: Reversal by sumatriptan. Lancet 338 13-17.
55. V. Gallai, P. Sarchielli, A. Floridi, M. Franceschini, M. Codini, A. Trequattrini and R. Palumbo (1995) Vasoactive peptide levels in the plasma of young migraine patients with and without aura assessed both interictally and ictally. Cephalalgia 15 384-390.
56. K. Gardner, M. Barmada, L.J. Ptacek and E.P. Hoffman (1997) A new locus for hemiplegic migraine maps to chromosome 1q31. Neurology 49 1231-1238.
57. M. Gervil, V. Ulrich, J. Kaprio, J. Olesen and M.B. Russell (1999) The relative role of genetic and environmental factors in migraine without aura. Neurology 53 995-999.
58. N.J. Giffin, R.B. Lipton, S.D. Silberstein, J.F. Tvedskov, J. Olesen and P.J. Goadsby (2005) The migraine postdrome: An electronic diary study. Cephalalgia 25 958.
59. N.J. Giffin, L. Ruggiero, R.B. Lipton, S. Silberstein, J.F. Tvedskov and J. Olesen (2003) Premonitory symptoms in migraine: An electronic diary study. Neurology 60 935-940.
60. P.J. Goadsby (2001) Migraine, aura and cortical spreading depression: Why are we still talking about it? Annals of Neurology 49 4-6.
61. P.J. Goadsby (2002) Neurovascular headache and a midbrain vascular malformation—Evidence for a role of the brainstem in chronic migraine. Cephalalgia 22 107-111.
62. P.J. Goadsby (2004) Prejunctional and presynaptic trigeminovascular targets: What preclinical evidence is there? Headache Currents 1 1-6.
63. P.J. Goadsby (2005) Calcitonin gene-related peptide antagonists as treatments of migraine and other primary headaches. Drugs 65 2557-2567.
64. P.J. Goadsby (2005) Can we develop neurally-acting drugs for the treatment of migraine? Nature Reviews Drug Discovery 4 741-750.
65. P.J. Goadsby (2005) Migraine pathophysiology. Headache 45 S14-S24.
66. P.J. Goadsby (2005) New targets in the acute treatment of headache. Current Opinion in Neurology 18 283-288.
67. P.J. Goadsby and L. Edvinsson (1994) Human in vivo evidence for trigeminovascular activation in cluster headache. Brain 117 427-434.
68. P.J. Goadsby and L. Edvinsson (1996) Neuropeptide changes in a case of chronic paroxysmal hemicrania—Evidence for trigemino-parasympathetic activation. Cephalalgia 16 448-450.
69. P.J. Goadsby, L. Edvinsson and R. Ekman (1988) Release of vasoactive peptides in the extracerebral circulation of man and the cat during activation of the trigeminovascular system. Annals of Neurology 23 193-196.
70. P.J. Goadsby, L. Edvinsson and R. Ekman (1990) Vasoactive peptide release in the extracerebral circulation of humans during migraine headache. Annals of Neurology 28 183-187.
71. P.J. Goadsby and K.L. Hoskin (1997) The distribution of trigeminovascular afferents in the nonhuman primate brain Macaca nemestrina: A c-fos immunocytochemical study. Journal of Anatomy 190 367-375.
72. P.J. Goadsby, K.L. Hoskin and Y.E. Knight (1997) Stimulation of the greater occipital nerve increases metabolic activity in the trigeminal nucleus caudalis and cervical dorsal horn of the cat. Pain 73 23-28.
73. P.J. Goadsby, G.A. Lambert and J.W. Lance (1982) Differential effects on the internal and external carotid circulation of the monkey evoked by locus coeruleus stimulation. Brain Research 249 247-254.
74. P.J. Goadsby, R.B. Lipton and M.D. Ferrari (2002) Migraine-current understanding and treatment. New England Journal of Medicine 346 257-270.
75. P.J. Goadsby, R.D. Piper, G.A. Lambert and J.W. Lance (1985) The effect of activation of the nucleus raphe dorsalis (DRN) on carotid blood flow. I: The Monkey. American Journal of Physiology 248 R257-R262.
76. P.J. Goadsby, R.D. Piper, G.A. Lambert and J.W. Lance (1985) The effect of activation of the nucleus raphe dorsalis (DRN) on carotid blood flow. II: The Cat. American Journal of Physiology 248 R263-R269.
77. P.J. Goadsby and A.S. Zagami (1991) Stimulation of the superior sagittal sinus increases metabolic activity and blood flow in certain regions of the brainstem and upper cervical spinal cord of the cat. Brain 114 1001-1011.
78. A.D. Grant, E. Pinter, A.M. Salmon and S.D. Brain (2005) An examination of neurogenic mechanisms involved in mustard oil-induced inflammation in the mouse. Eur J Pharmacol 507 273-280.
79. S. Guida, F. Trettel, S. Pagnutti, E. Mantuano, A. Tottene and L. Veneziano (2001) Complete loss of P/Q calcium channel activity caused by a CACNA1A missense mutation carried by patients with episodic ataxia type 2. Am J Hum Genet 68 759-764.
80. J. Haan, E.E. Kors, K.R. Vanmolkot, A.M. van den Maagdenberg, R.R. Frants and M.D. Ferrari (2005) Migraine genetics: an update. Curr Pain Headache Rep 9 213-220.
81. N. Hadjikhani, M. Sanchez del Rio, O. Wu, D. Schwartz, D. Bakker and B. Fischl (2001) Mechanisms of migraine aura revealed by functional MRI in human visual cortex. Proceedings of the National Academy of Sciences (USA) 98 4687-4692.
82. K. Haerter, C. Ayata and M.A. Moskowitz (2005) Cortical spreading depression: A model for understanding migraine biology and future drug targets. Headache Currents 2 97-103.
83. M. Hans, S. Luvisetto, M.E. Williams, M. Spagnolo, A. Urrutia and A. Tottene (1999) Functional consequences of mutations in the human alpha(1A) calcium channel subunit linked to familial hemiplegic migraine. Journal of Neuroscience 19 1610-1619.
84. S.R. Haut, M.E. Bigal and R.B. Lipton (2006) Chronic disorders with episodic manifestations: Focus on epilepsy and migraine. Lancet Neurol 5 148-157.
85. Headache Classification Committee of The International Headache Society (2004) The International Classification of Headache Disorders (second edition). Cephalalgia 24 1-160.
86. J.N. Hirschhorn and M.J. Daly (2005) Genome-wide association studies for common diseases and complex traits. Nat Rev Genet 6 95-108.
87. M.-L. Honkasalo, J. Kaprio, T. Winter, K. Heikkilä, M. Sillanpää and M. Koskenvuo (1995) Migraine and concomitant symptoms among 8167 adult twin pairs. Headache 35 70-78.
88. K.L. Hoskin, D.C.E. Bulmer, M. Lasalandra, A. Jonkman and P.J. Goadsby (2001) Fos expression in the midbrain periaqueductal grey after trigeminovascular stimulation. Journal of Anatomy 197 29-35.
89. K.L. Hoskin, H. Kaube and P.J. Goadsby (1996) Central activation of the trigeminovascular pathway in the cat is inhibited by dihydroergotamine. A c-Fos and electrophysiology study. Brain 119 249-256.
90. K.L. Hoskin, A. Zagami and P.J. Goadsby (1999) Stimulation of the middle meningeal artery leads to Fos expression in the trigeminocervical nucleus: A comparative study of monkey and cat. Journal of Anatomy 194 579-588.
91. J.J. Hottenga, K.R. Vanmolkot, E.E. Kors, S. Kheradmand Kia, P.T. de Jong and J. Haan (2005) The 3p21.1-p21.3 hereditary vascular retinopathy locus increases the risk for Raynaud's phenomenon and migraine. Cephalalgia 25 1168-1172.
92. K. Ikeda, T. Onaka, M. Yamakado, J. Nakai, T.O. Ishikawa, M.M. Taketo and K. Kawakami (2003) Degeneration of the amygdala/piriform cortex and enhanced fear/anxiety behaviors in sodium pump alpha2 subunit (Atp1a2)-deficient mice. J Neurosci 23 4667-4676.
93. K. Ikeda, H. Onimaru, J. Yamada, K. Inoue, S. Ueno and T. Onaka (2004) Malfunction of respiratory-related neuronal activity in Na+, K+-ATPase alpha2 subunit-deficient mice is attributable to abnormal Cl- homeostasis in brainstem neurons. J Neurosci 24 10693-10701.
94. P. Imbrici, S.L. Jaffe, L.H. Eunson, N.P. Davies, C. Herd and R. Robertson (2004) Dysfunction of the brain calcium channel Ca V2.1 in absence epilepsy and episodic ataxia. Brain 127 2682-2692.
95. H. Iversen (2001) Human migraine models. Cephalalgia 21 781-785.
96. P.F. James, I.L. Grupp, G. Grupp, A.L. Woo, G.R. Askew and M.L. Croyle (1999) Identification of a specific role for the Na,K-ATPase alpha 2 isoform as a regulator of calcium in the heart. Mol Cell 3 555-563.
97. J. Jen, G.W. Kim and R.W. Baloh (2004) Clinical spectrum of episodic ataxia type 2. Neurology 62 17-22.
98. J. Jen, J. Wan, M. Graves, H. Yu, A.F. Mock and C.J. Coulin (2001) Loss-of-function EA2 mutations are associated with impaired neuromuscular transmission. Neurology 57 1843-1848.
99. C.J. Jeng, Y.T. Chen, Y.W. Chen and C.Y. Tang (2006) Dominant-negative effects of human P/Q-type Ca2+ channel mutations associated with episodic ataxia type 2. Am J Physiol Cell Physiol 290 1209-1220.
100. A. Joutel, C. Corpechot, A. Ducros, K. Vahedi, H. Chabriat and P. Mouton (1996) Notch3 mutations in CADASIL, a hereditary adult-onset condition causing stroke and dementia. Nature 383 707-710.
101. A. Jouvenceau, L.H. Eunson, A. Spauschus, V. Ramesh, S.M. Zuberi, D.M. Kullmann and M.G. Hanna (2001) Human epilepsy associated with dysfunction of the brain P/Q-type calcium channel. Lancet 358 801-807.
102. G. Juhasz, T. Zsombok, B. Jakab, J. Nemeth, J. Szolcsanyi and G. Bagdy (2005) Sumatriptan causes parallel decrease in plasma calcitonin gene-related peptide (CGRP) concentration and migraine headache during nitroglycerin induced migraine attack. Cephalalgia 25 179-183.
103. G. Juhasz, T. Zsombok, E.A. Modos, S. Olajos, B. Jakab and J. Nemeth (2003) NO-induced migraine attack: Strong increase in plasma calcitonin gene-related peptide (CGRP) concentration and negative correlation with platelet serotonin release. Pain 106 461-470.
104. K. Jun, E.S. Piedras-Renteria, S.M. Smith, D.B. Wheeler, S.B. Lee and T.G. Lee (1999) Ablation of P/Q-Type Ca(2+) channel currents, altered synaptic transmission, and progressive ataxia in mice lacking the alpha(1A)- subunit. Proceedings of the National Academy of Science USA 96 15245-15250.
105. M. Kallela, M. Wessman, H. Havanka, A. Palotie and M. Farkkila (2001) Familial migraine with and without aura: Clinical charecteristics and co-occurence. European Journal of Neurology 8 441-449.
106. K. Kanai, S. Hirose, H. Oguni, G. Fukuma, Y. Shirasaka and T. Miyajima (2004) Effect of localization of missense mutations in SCN1A on epilepsy phenotype severity. Neurology 63 329-334.
107. I. Kara, A. Sazci, E. Ergul, G. Kaya and G. Kilic (2003) Association of the C677T and A1298C polymorphisms in the 5,10 methylenetetrahydrofolate reductase gene in patients with migraine risk. Brain Res Mol Brain Res 111 84-90.
108. H. Kaube and N.J. Giffin (2002) The electrophysiology of migraine. Current Opinion in Neurology 15 303-309.
109. H. Kaube, J. Herzog, T. Kaufer, M. Dichgans and H.C. Diener (2000) Aura in some patients with familial hemiplegic migraine can be stopped by intranasal ketamine. Neurology 55 139-141.
110. H. Kaube, K.A. Keay, K.L. Hoskin, R. Bandler and P.J. Goadsby (1993) Expression of c- Fos-like immunoreactivity in the caudal medulla and upper cervical cord following stimulation of the superior sagittal sinus in the cat. Brain Research 629 95-102.
111. L. Kelman (2004) The premonitory symptoms (prodrome): A tertiary care study of 893 migraineurs. Headache 44 865-872.
112. L. Kelman (2006) The postdrome of the acute migraine attack. Cephalalgia 26 214-220.
113. Y.E. Knight, T. Bartsch and P.J. Goadsby (2003) Trigeminal antinociception induced by bicuculline in the periaqueductal grey (PAG) is not affected by PAG P/Q-type calcium channel blockade in rat. Neuroscience Letters 336 113-116.
114. Y.E. Knight, T. Bartsch, H. Kaube and P.J. Goadsby (2002) P/Q-type calcium channel blockade in the PAG facilitates trigeminal nociception: A functional genetic link for migraine? Journal of Neuroscience 22 1-6.
115. Y.E. Knight and P.J. Goadsby (2001) The periaqueductal gray matter modulates trigeminovascular input: A role in migraine? Neuroscience 106 793-800.
116. E.E. Kors, G.M. Terwindt, F.L.M.G. Vermeulen, R.B. Fitzsimons, P.E. Jardine and P. Heywood (2001) Delayed cerebral edema and fatal coma after minor head trauma: Role of CACNA1A calcium channel subunit gene and relationship with familial hemiplegic migraine. Annals of Neurology 49 753-760.
117. E.E. Kors, K.R. Vanmolkot, J. Haan, R.R. Frants, A.M. van den Maagdenberg and M.D. Ferrari (2004) Recent findings in headache genetics. Curr Opin Neurol 17 283-288.
118. H. Kowa, E. Fusayasu, T. Ijiri, K. Ishizaki, K. Yasui and K. Nakaso (2005) Association of the insertion/deletion polymorphism of the angiotensin I-converting enzyme gene in patients of migraine with aura. Neurosci Lett 374 129-131.
119. H. Kowa, K. Yasui, T. Takeshima, K. Urakami, F. Sakai and K. Nakashima (2000) The homozygous C677T mutation in the methylenetetrahydrofolate reductase gene is a genetic risk factor for migraine. Am J Med Genet 96 762-764.
120. R.L. Kraus, M.J. Sinnegger, H. Glossmann, S. Hering and J. Striessnig (1998) Familial hemiplegic migraine mutations change alpha(1A) Ca 2+ channel kinetics. Journal of Biological Chemistry 273 5586-5590.
121. R.L. Kraus, M.J. Sinnegger, A. Koschak, H. Glossmann, S. Stenirri, P. Carrera and J. Striessnig (2000) Three new familial hemiplegic migraine mutants affect P/Q-type Ca(2+) channel kinetics. Journal of Biological Chemistry 275 9239-9243.
122. M.C. Kruit, M.A. van Buchem, P.A. Hofman, J.T. Bakkers, G.M. Terwindt, M.D. Ferrari and L.J. Launer (2004) Migraine as a risk factor for subclinical brain lesions. Journal of the American Medical Association 291 427-434.
123. J.W. Lance and P.J. Goadsby (2005) Mechanism and management of headache Elsevier: New York
124. K.S. Lashley (1941) Patterns of cerebral integration indicated by the scotomas of migraine. Archives of Neurology and Psychiatry 46 331-339.
125. M. Lauritzen (1994) Pathophysiology of the migraine aura. The spreading depression theory. Brain 117 199-210.
126. R.A. Lea, D.R. Nyholt, R.P. Curtain, M. Ovcaric, R. Sciascia and C. Bellis (2005) A genome-wide scan provides evidence for loci influencing a severe heritable form of common migraine. Neurogenetics 6 67-72.
127. R.A. Lea, M. Ovcaric, J. Sundholm, J. MacMillan and L.R. Griffiths (2004) The methylenetetrahydrofolate reductase gene variant C677T influences susceptibility to migraine with aura. BMC Med 2 3.
128. R.A. Lea, M. Ovcaric, J. Sundholm, L. Solyom, J. Macmillan and L.R. Griffiths (2005) Genetic variants of angiotensin converting enzyme and methylenetetrahydrofolate reductase may act in combination to increase migraine susceptibility. Brain Res Mol Brain Res 136 112-117.
129. B. Levant and K.E. McCarson (2001) D(3) dopamine receptors in rat spinal cord: implications for sensory and motor function. Neurosci Lett 303 9-12.
130. A.I. Levey, S.M. Hersch, D.B. Rye, R.K. Sunahara, H.B. Niznik and C.A. Kitt (1993) Localization of D1 and D2 dopamine receptors in brain with subtype-specific antibodies. Proc Natl Acad Sci U S A 90 8861-8865.
131. M.J. Levy, M.S. Matharu and P.J. Goadsby (2003) Prolactinomas, dopamine agonist and headache: Two case reports. European Journal of Neurology 10 169-174.
132. V. Limmroth, A. May, P. Auerbach, G. Wosnitza, T. Eppe and H.C. Diener (1996) Changes in cerebral blood flow velocity after treatment with sumatriptan or placebo and implications for the pathophysiology of migraine. Journal of Neurological Sciences 138 60-65.
133. J.J. Lin, P.J. Wang, C.H. Chen, K.C. Yueh, S.Z. Lin and H.J. Harn (2005) Homozygous deletion genotype of angiotensin converting enzyme confers protection against migraine in man. Acta Neurol Taiwan 14 120-125.
134. R.B. Lipton, W.F. Stewart, S. Diamond, M.L. Diamond and M. Reed (2001) Prevalence and burden of migraine in the United States: Data from the American Migraine Study II. Headache 41 646-657.
135. N.M. Lorenzon, C.M. Lutz, W.N. Frankel and K.G. Beam (1998) Altered calcium channel currents in purkinje cells of neurological mutant mouse leaner. Journal of Neuroscience 18 4482-4489.
136. P. Ludvigsson, D. Hesdorffer, E. Olafsson, O. Kjartansson and W.A. Hauser (2006) Migraine with aura is a risk factor for unprovoked seizures in children. Ann Neurol 59 210-213.
137. J. Lundkvist, S. Zhu, E.M. Hansson, P. Schweinhardt, Q. Miao and P. Beatus (2005) Mice carrying a R142C Notch 3 knock-in mutation do not develop a CADASIL-like phenotype. Genesis 41 13-22.
138. S. Maneesi, S. Akerman, M.P. Lasalandra, J.D. Classey and P.J. Goadsby (2004) Electron microsopic demonstration of pre- and postsynaptic 5-HT 1D and 5-HT 1F receptor immunoreactivity (IR) in the rat trigeminocervical complex (TCC) new therapeutic possibilities for the triptans. Cephalalgia 24 148.
139. R. Marconi, M. De Fusco, P. Aridon, K. Plewnia, M. Rossi and S. Carapelli (2003) Familial hemiplegic migraine type 2 is linked to 0.9Mb region on chromosome 1q23. Ann Neurol 53 376-381.
140. M.S. Matharu, T. Bartsch, N. Ward, R.S.J. Frackowiak, R.L. Weiner and P.J. Goadsby (2004) Central neuromodulation in chronic migraine patients with suboccipital stimulators: A PET study. Brain 127 220-230.
141. M.S. Matharu and P.J. Goadsby (2001) Post-traumatic chronic paroxysmal hemicrania (CPH) with aura. Neurology 56 273-275.
142. M.S. Matharu and P.J. Goadsby (2005) Functional brain imaging in hemicrania continua: Implications for nosology and pathophysiology. Current Pain and Headache Reports 9 281-288.
143. A. May and P.J. Goadsby (1999) The trigeminovascular system in humans: Pathophysiological implications for primary headache syndromes of the neural influences on the cerebral circulation. Journal of Cerebral Blood Flow and Metabolism 19 115-127.
144. A. May and P.J. Goadsby (2001) Substance P receptor antagonists in the therapy of migraine. Expert Opinion in Investigational Drugs 10 1-6.
145. A. May, S. Shepheard, A. Wessing, R.J. Hargreaves, P.J. Goadsby and H.C. Diener (1998) Retinal plasma extravasation can be evoked by trigeminal stimulation in rat but does not occur during migraine attacks. Brain 121 1231-1237.
146. F.L. McNaughton (1938) The innervation of the intracranial blood vessels and dural sinuses. Proceedings of the Association for Research in Nervous & Mental Diseases 18 178-200.
147. F.L. McNaughton (1966) The innervation of the intracranial blood vessels and the dural sinuses. S. Cobb, A.M. Frantz, W. Penfield, H.A. Riley (Eds) The circulation of the brain and spinal cord New York: Hafner Publishing Co. Inc 178-200.
148. M.H. Meisler and J.A. Kearney (2005) Sodium channel mutations in epilepsy and other neurological disorders. J Clin Invest 115 2010-2017.
149. M. Menken, T.L. Munsat and J.F. Toole (2000) The global burden of disease study—Implications for neurology. Archives of Neurology 57 418-420.
150. E. Mogilnicka and V. Klimek (1977) Drugs affecting dopamine neurons and yawning behavior. Pharmacol Biochem Behav 7 303-305.
151. P. Montagna, G. Pierangeli, S. Cevoli, M. Mochi and P. Cortelli (2005) Pharmacogenetics of headache treatment. Neurological Sciences 26 S143-S147.
152. Y. Mori, M. Wakamori, S. Oda, C.F. Fletcher, N. Sekiguchi and E. Mori (2000) Reduced voltage sensitivity of activation of P/Q-type Ca 2+ channels is associated with the ataxic mouse mutation rolling Nagoya (tg(rol)). Journal of Neuroscience 20 5654-5662.
153. M.A. Moskowitz, H. Bolay and T. Dalkara (2004) Deciphering migraine mechanisms: Clues from familial hemiplegic migraine genotypes. Ann Neurol 55 276-280.
154. M.A. Moskowitz and F.M. Cutrer (1993) SUMATRIPTAN: A receptor-targeted treatment for migraine. Annual Review of Medicine 44 145-154.
155. E.J. Mulder, C. Van Baal, D. Gaist, M. Kallela, J. Kaprio and D.A. Svensson (2003) Genetic and environmental influences on migraine: A twin study across six countries. Twin Research 6 422-431.
156. C. Mullner, L.A. Broos, A.M. van den Maagdenberg and J. Striessnig (2004) Familial hemiplegic migraine type 1 mutations K1336E, W1684R, and V1696I alter Cav2.1 Ca2+ channel gating: Evidence for beta-subunit isoform-specific effects. J Biol Chem 279 51844-51850.
157. E. Niebur, S.S. Hsiao and K.O. Johnson (2002) Synchrony: A neural mechanism for attentional selection? Current Opinion in Neurobiology 12 190-194.
158. D.R. Nyholt, J.L. Dawkins, P.J. Brimage, P.J. Goadsby, G.A. Nicholson and L.R. Griffiths (1998) Evidence for an X-linked genetic component in familial typical migraine. Human Molecular Genetics 7 459-463.
159. D.R. Nyholt, N.G. Gillespie, A.C. Heath, K.R. Merikangas, D.L. Duffy and N.G. Martin (2004) Latent class and genetic analysis does not support migraine with aura and migraine without aura as separate entities. Genet Epidemiol 26 231-244.
160. D.R. Nyholt, K.I. Morley, M.A. Ferreira, S.E. Medland, D.I. Boomsma and A.C. Heath (2005) Genomewide significant linkage to migrainous headache on chromosome 5q21. Am J Hum Genet 77 500-512.
161. M. Obermann, E.R. Gizewski, V. Limmroth, H.-C. Diener and Z. Katsarava (2006) Symptomatic migraine and pontine vascular malformation: Evidence for a key role of the brainstem in the pathophysiology of chronic migraine. Cephalalgia 26 in press
162. J. Olesen, H.-C. Diener, I.-W. Husstedt, P.J. Goadsby, D. Hall and U. Meier (2004) Calcitonin gene-related peptide (CGRP) receptor antagonist BIBN4096BS is effective in the treatment of migraine attacks. New England Journal of Medicine 350 1104-1110.
163. R.A. Ophoff, J. DeYoung, S.K. Service, M. Joosse, N.A. Caffo and L.A. Sandkuijl (2001) Hereditary vascular retinopathy, cerebroretinal vasculopathy, and hereditary endotheliopathy with retinopathy, nephropathy and stroke map to a single locus on chromosome 3p21.1-p21.3. Am J Hum Genet 69 447-453.
164. R.A. Ophoff, G.M. Terwindt, M.N. Vergouwe, R. van Eijk, P.J. Oefner and S.M.G. Hoffman (1996) Familial hemiplegic migraine and episodic ataxia type-2 are caused by mutations in the Ca 2+ channel gene CACNL1A4. Cell 87 543-552.
165. A. Oterino, J. Pascual, C. Ruiz de Alegria, N. Valle, J. Castillo and Y. Bravo (2006) Association of migraine and ESR1 G325C polymorphism. Neuroreport 17 61-64.
166. A. Oterino, N. Valle, Y. Bravo, P. Munoz, P. Sanchez-Velasco and C. Ruiz-Alegria (2004) MTHFR T677 homozygosis influences the presence of aura in migraineurs. Cephalalgia 24 491-494.
167. S. Paterna, P. Di Pasquale, A. D'Angelo, G. Seidita, A. Tuttolomondo and A. Cardinale (2000) Angiotensin-converting enzyme gene deletion polymorphism determines an increase in frequency of migraine attacks in patients suffering from migraine without aura. Eur Neurol 43 133-136.
168. M.F.P. Peres, H.C. Siow and T.D. Rozen (2002) Hemicrania continua with aura. Cephalalgia 22 246-248.
169. S.J. Peroutka (2005) Neurogenic inflammation and migraine: Implications for therapeutics. Molecular Interventions 5 306-313.
170. D. Pietrobon (2005) Function and dysfunction of synaptic calcium channels: Insights from mouse models. Curr Opin Neurobiol 15 257-265.
171. R.D. Piper, G.A. Lambert and J.W. Duckworth (1991) Cortical blood flow changes during spreading depression in cats. American Journal of Physiology 261 H96-H102.
172. P. Pozo-Rosich and M. Oshinsky (2005) Effect of dihydroergotamine (DHE) on central sensitisation of neurons in the trigeminal nucleus caudalis. Neurology 64 A151.
173. P. Protais, I. Dubuc and J. Costentin (1983) Pharmacological characteristics of dopamine receptors involved in the dual effect of dopamine agonists on yawning behaviour in rats. Eur J Pharmacol 94 271-280.
174. F. Radat and J. Swendsen (2005) Psychiatric comorbidity in migraine: A review. Cephalalgia 25 165-178.
175. I. Rainero, L.M. Grimaldi, G. Salani, W. Valfre, C. Rivoiro, L. Savi and L. Pinessi (2004) Association between the tumor necrosis factor-alpha-08 G/A gene polymorphism and migraine. Neurology 62 141-143.
176. N.H. Raskin, Y. Hosobuchi and S. Lamb (1987) Headache may arise from perturbation of brain. Headache 27 416-420.
177. F. Riant, M. De Fusco, P. Aridon, A. Ducros, C. Ploton and F. Marchelli (2005) ATP1A2 mutations in 11 families with familial hemiplegic migraine. Hum Mutat 26 281.
178. M.M. Ruchoux, V. Domenga, P. Brulin, J. Maciazek, S. Limol, E. Tournier-Lasserve and A. Joutel (2003) Transgenic mice expressing mutant Notch3 develop vascular alterations characteristic of cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy. Am J Pathol 162 329-342.
179. M.B. Russell and J. Olesen (1995) Increased familial risk and evidence of genetic factor in migraine. British Medical Journal 311 541-544.
180. M.B. Russell and J. Olesen (1996) A nosographic analysis of the migraine aura in a general population. Brain 119 355-361.
181. M.B. Russell, V. Ulrich, M. Gervil and J. Olesen (2002) Migraine without aura and migraine with aura are distinct disorders. A population-based twin survey. Headache 42 332-336.
182. L. Russo, P. Mariotti, E. Sangiorgi, T. Giordano, I. Ricci and F. Lupi (2005) A new susceptibility locus for migraine with aura in the 15q11-q13 genomic region containing three GABA-A receptor genes. Am J Hum Genet 76 327-333.
183. P.S. Sandor, A. Mascia, L. Seidel, V. de Pasqua and J. Schoenen (2001) Subclinical cerebellar impairment in the common types of migraine: A three-dimensional analysis of reaching movements. Annals of Neurology 49 668-672.
184. A.I. Scher, W.F. Stewart and R.B. Lipton (1999) Migraine and headache: A meta-analytic approach. I.K. Crombie (Eds) Epidemiology of Pain Seattle, Washington: IASP Press 159-170.
185. A.I. Scher, G.M. Terwindt, W.M. Verschuren, M.C. Kruit, H.J. Blom and H. Kowa (2006) Migraine and MTHFR C677T genotype in a population-based sample. Ann Neurol 59 372-375.
186. J. Schoenen, A. Ambrosini, P.S. Sandor and A. Maertens de Noordhout (2003) Evoked potentials and transcranial magnetic stimulation in migraine: Published data and viewpoint on their pathophysiologic significance. Clinical Neurophysiology 114 955-972.
187. L. Segall, A. Mezzetti, R. Scanzano, J.J. Gargus, E. Purisima and R. Blostein (2005) Alterations in the alpha 2 isoform of Na,K-ATPase associated with familial hemiplegic migraine type 2. Proc Natl Acad Sci U S A 102 11106-11111.
188. G. Selby and J.W. Lance (1960) Observations on 500 cases of migraine and allied vascular headache. Journal of Neurology, Neurosurgery and Psychiatry 23 23-32.
189. G. Serra, M. Collu and G.L. Gessa (1986) Dopamine receptors mediating yawning: Are they autoreceptors? European Journal of Pharmacology 120 187-192.
190. K.G. Shields and P.J. Goadsby (2005) Propranolol modulates trigeminovascular responses in thalamic ventroposteromedial nucleus: A role in migraine? Brain 128 86-97.
191. K.G. Shields and P.J. Goadsby (2006) Serotonin receptors modulate trigeminovascular responses in ventroposteromedial nucleus of thalamus: A migraine target? Neurobiology of Disease in press
192. K.G. Shields, H. Kaube and P.J. Goadsby (2003) GABA receptors modulate trigeminovascular nociceptive transmission in the ventroposteromedial (VPM) thalamic nucleus of the rat. Cephalalgia 23 728.
193. K.G. Shields, R.J. Storer, S. Akerman and P.J. Goadsby (2005) Calcium channels modulate nociceptive transmission in the trigeminal nucleus of the cat. Neuroscience 135 203-212.
194. S.D. Silberstein, R.B. Lipton and P.J. Goadsby (2002) Headache in Clinical Practice London: Martin Dunitz
195. S.D. Silberstein, R. Niknam, T.D. Rozen and W.B. Young (2000) Cluster headache with aura. Neurology 54 219-221.
196. G. Skagerberg, A. Bjorklund, O. Lindvall and R.H. Schmidt (1982) Origin and termination of the diencephalo-spinal dopamine system in the rat. Brain Res Bull 9 237-244.
197. G.G. Somjen (2001) Mechanisms of spreading depression and hypoxic spreading depression-like depolarization. Physiol. Rev. 81 1065-1096.
198. D. Soragna, A. Vettori, G. Carraro, E. Marchioni, G. Vazza, S., R., T. Bellini, et al. (2003) A locus for migraine without aura maps on chromosome 14q21.2-q22.3. Am J Hum Genet 72 161-167.
199. S.D. Spacey, M.E. Hildebrand, L.A. Materek, T.D. Bird and T.P. Snutch (2004) Functional implications of a novel EA2 mutation in the P/Qtype calcium channel. Ann Neurol 56 213-220.
200. M. Spadaro, S. Ursu, F. Lehmann-Horn, L. Veneziano, G. Antonini and P. Giunti (2004) A G301R Na+/K+-ATPase mutation causes familial hemiplegic migraine type 2 with cerebellar signs. Neurogenetics 5 177-185.
201. W.F. Stewart, M.E. Bigal, K. Kolodner, A. Dowson, J.N. Liberman and R.B. Lipton (2006) Familial risk of migraine: Variation by proband age at onset and headache severity. Neurology 66 344-348.
202. W.F. Stewart, J.A. Ricci, E. Chee, D. Morganstein and R. Lipton (2003) Lost productive time and cost due to common pain conditions in the US workforce. JAMA 290 2443-2454.
203. W.F. Stewart, J. Staffa, R.B. Lipton and R. Ottman (1997) Familial risk of migraine: A population-based study. Annals of Neurology 41 166-172.
204. D.A. Svensson, B. Larsson, E. Waldenlind and N.L. Pedersen (2003) Shared rearing environment in migraine: Results from twins reared apart and twins reared together. Headache 43 235-244.
205. K.J. Swoboda, E. Kanavakis, A. Xaidara, J.E. Johnson, M.F. Leppert, M.B. Schlesinger-Massart, et al. (2004) Alternating hemiplegia of childhood or familial hemiplegic migraine?: A novel ATP1A2 mutation. Annals of Neurology 55 884-887.
206. G. Terwindt, E. Kors, J. Haan, F. Vermeulen, A. Van den Maagdenberg, R. Frants and M. Ferrari (2002) Mutation analysis of the CACNA1A calcium channel subunit gene in 27 patients with sporadic hemiplegic migraine. Arch Neurol 59 1016-1018.
207. G.M. Terwindt, J. Haan, R.A. Ophoff, S.M.A. Groenen, C. Storimans and J.B.K. Lanser (1998) Clinical and genetic analysis of a large Dutch family with autosomal dominant vascular retinopathy, migraine and Raynaud's phenomenon. Brain 121 303-316.
208. G.M. Terwindt, E.E. Kors, A.A. Vein, M.D. Ferrari and J.G. van Dijk (2004) Single-fiber EMG in familial hemiplegic migraine. Neurology 63 1942-1943.
209. G.M. Terwindt, R.A. Ophoff, J. Haan, M.N. Vergouwe, R. van Eijk, R.R. Frants and M.D. Ferrari (1998) Variable clinical expression of mutations in the P/Q-type calcium channel gene in familial hemiplegic migraine. Neurology 50 1105-1110.
210. L.L. Thomsen, E. Ostergaard, J. Olesen and M.B. Russell (2003) Evidence for a separate type of migraine with aura: Sporadic hemiplegic migraine. Neurology 60 595-601.
211. L.L. Thomsen, E. Ostergaard, S.F. Romer, I. Andersen, M.K. Eriksen, J. Olesen and M.B. Russell (2003) Sporadic hemiplegic migraine is an aetiologically heterogeneous disorder. Cephalalgia 23 921-928.
212. U. Todt, M. Dichgans, K. Jurkat-Rott, A. Heinze, G. Zifarelli and J.B. Koenderink (2005) Rare missense variants in ATP1A2 in families with clustering of common forms of migraine. Hum Mutat 26 315-321.
213. A. Tottene, F. Pivotto, T. Fellin, T. Cesetti, A.M. van den Maagdenberg and D. Pietrobon (2005) Specific kinetic alterations of human CaV2.1 calcium channels produced by mutation S218L causing familial hemiplegic migraine and delayed cerebral edema and coma after minor head trauma. J Biol Chem 280 17678-17686.
214. A. Tottene, A. Tottene, T. Fellin, S. Pagnutti, S. Luvisetto and J. Striessnig (2002) Familial hemiplegic migraine mutations increase Ca 2+ influx through single human CaV2.1 channels and decrease maximal Ca V2.1 current density in neurons. Proceedings of the National Academy of Science USA 99 13284-13289.
215. E. Tournier-Lasserve, A. Joutel, J. Melki, J. Weissenbach, G.M. Lathrop and H. Chabriat (1993) Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy maps to chromosome 19p12. Nature Genetics 3 256-259.
216. S. Trabace, G. Brioli, P. Lulli, M. Morellini, M. Giacovazzo, G. Cicciarelli and P. Martelletti (2002) Tumor necrosis factor gene polymorphism in migraine. Headache 42 341-345.
217. J.F. Tvedskov, K. Lipka, M. Ashina, H.K. Iversen, S. Schifter and J. Olesen (2005) No increase of calcitonin gene-related peptide in jugular blood during migraine. Ann Neurol 58 561-568.
218. J.F. Tvedskov, L.L. Thomsen, H.K. Iversen, A. Gibson, P. Wiliams and J. Olesen (2004) The prophylactic effect of valproate on glyceryl trinitrate induced migraine. Cephalalgia 24 576-585.
219. J.F. Tvedskov, L.L. Thomsen, H.K. Iversen, P. Williams, A. Gibson and K. Jenkins (2004) The effect of propranolol on glyceryl trinitrate-induced headache and arterial response. Cephalalgia 24 1076-1087.
220. V. Ulrich, M. Gervil, K.O. Kyvik, J. Olesen and M.B. Russell (1999) Evidence of a genetic factor in migraine with aura: A population based Danish twin study. Annals of Neurology 45 242-246.
221. A.M.J.M. van den Maagdenberg, D. Pietrobon, T. Pizzorusso, S. Kaja, L.A.M. Broos and T. Cesetti (2004) A Cacna1a knock-in migraine mouse model with increased susceptibility to cortical spreading depression. Neuron 41 701-710.
222. H. van Dijken, J. Dijk, P. Voom and J.C. Holstege (1996) Localization of dopamine D2 receptor in rat spinal cord identified with immunocytochemistry and in situ hybridization. Eur J Neurosci 8 621-628.
223. K.R. Vanmolkot, E.E. Kors, U. Turk, D. Turkdogan, A. Keyser and L.A. Broos (2006) Two de novo mutations in the Na,K-ATPase gene ATP1A2 associated with pure familial hemiplegic migraine. Eur J Hum Genet 14 555-560.
224. K.R.J. Vanmolkot, E.E. Kors, J.J. Hottenga, G.M. Terwindt, J. Haan and W.A.J. Hoefnagels (2003) Novel mutations in the Na +,K +-ATPase pump gene ATP1A2 associated with Familial Hemiplegic Migraine and Benign Familial Infantile Convulsions. Annals of Neurology 54 360-366.
225. J. Waelkens (1981) Domperidone in the prevention of complete classical migraine. British Medical Journal 284 944.
226. J. Waelkens (1984) Dopamine blockade with domperidone: Bridge between prophylactic and abortive treatment of migraine? A dose-finding study. Cephalalgia 4 85-90.
227. M. Wakamori, K. Yamazaki, H. Matsunodaira, T. Teramoto, I. Tanaka and T. Niidome (1998) Single tottering mutations responsible for the neuropathic phenotype of the P-Type calcium channel. Journal of Biological Chemistry 273 34857-34867.
228. J. Wan, R. Khanna, M. Sandusky, D.M. Papazian, J.C. Jen and R.W. Baloh (2005) CACNA1A mutations causing episodic and progressive ataxia alter channel trafficking and kinetics. Neurology 64 2090-2097.
229. E. Wappl, A. Koschak, M. Poteser, M.J. Sinnegger, D. Walter and A. Eberhart (2002) Functional consequences of P/Q-type Ca2+ channel Cav2.1 missense mutations associated with episodic ataxia type 2 and progressive ataxia. J Biol Chem 277 6960-6966.
230. C. Weiller, A. May, V. Limmroth, M. Juptner, H. Kaube and R.V. Schayck (1995) Brain stem activation in spontaneous human migraine attacks. Nature Medicine 1 658-660.
231. K.M. Welch, V. Nagesh, S. Aurora and N. Gelman (2001) Periaqueductal grey matter dysfunction in migraine: Cause or the burden of illness? Headache 41 629-637.
232. K.M.A. Welch (2005) Brain hyperexcitability: The basis for antiepileptic drugs in migraine prevention. Headache 45 S25-S32.
233. M. Wessman, M. Kallela, M.A. Kaunisto, P. Marttila, E. Sobel and J. Hartiala (2002) A susceptibility locus for migraine with aura, on chromosome 4q24. American Journal of Human Genetics 70 652-662.
234. F. Wilkinson, O. Karanovic, E.C. Ross, L. Lillakas and M.J. Steinbach (2006) Ocular motor measures in migraine with and without aura. Cephalalgia 26 660-671.
235. H.G. Wolff (1963) Headache and Other Head Pain New York: Oxford University Press
236. R.P. Woods, M. Iacoboni and J.C. Mazziotta (1994) Bilateral spreading cerebral hypoperfusion during spontaneous migraine headache. New England Journal of Medicine 331 1689-1692.
237. C.J. Woolf (1996) Windup and central sensitization are not equivalent. Pain 66 105-108.
238. K. Yamada, M. Tanaka, K. Shibata and T. Furukawa (1986) Involvement of septal and striatal dopamine D-2 receptors in yawning behavior in rats. Psychopharmacology (Berl) 90 9-13.
239. Q. Yue, J.C. Jen, S.F. Nelson and R.W. Baloh (1997) Progressive ataxia due to a missense mutation in a calcium-channel gene. Am J Hum Genet 61 1078-1087.
240. A.S. Zagami, P.J. Goadsby and L. Edvinsson (1990) Stimulation of the superior sagittal sinus in the cat causes release of vasoactive peptides. Neuropeptides 16 69-75.
241. A.S. Zagami and G.A. Lambert (1990) Stimulation of cranial vessels excites nociceptive neurones in several thalamic nuclei of the cat. Experimental Brain Research 81 552-566.
242. A.S. Zagami and G.A. Lambert (1991) Craniovascular application of capsaicin activates nociceptive thalamic neurons in the cat. Neuroscience Letters 121 187-190.
243. O. Zhuchenko, J. Bailey, P. Donnen, T. Ashizawa, D.W. Stockton and C. Amos (1997) Autosomal dominant cerebellar ataxia (SCA6) associated with small polyglutamine expansions in the α1A-voltage-dependent calcium channel. Nature Genetics 15 62-69.
244. D.K. Ziegler, Y.M. Hur, T.J. Bouchard Jr, R.S. Hassanein and R., B. Hassanein (1998) Migraine in twins raised together and apart. Headache 38 417-422.